CGC — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Canopy Growth Corporation
Healthcare · $1
4.4
/10
Neutral
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-18.6%
Below trend
Volatility
Low
Thin premiums
Momentum
Accelerating
Price direction
About Canopy Growth Corporation
Canadian cannabis producer with cultivation, distribution, and retail operations. No dividend, very high beta, persistent losses, and heavy dilution history. Sentiment-driven swings tied to legalization headlines. Premiums look tempting but assignment risk is real — speculative CSP only.
Drug Manufacturers - Specialty & Generic
Market Cap
$449M
Beta
2.32
52-Week Range Current: $1
$0.77 $2.38
Earnings
2026-05-29
54 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE